<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03731429</url>
  </required_header>
  <id_info>
    <org_study_id>201824</org_study_id>
    <nct_id>NCT03731429</nct_id>
  </id_info>
  <brief_title>Lidocaine to Prevent Cough and Hemodynamic Changes in Tracheal Extubation</brief_title>
  <official_title>Efficiency of Intravenous Lidocaine to Reduce Coughing and the Hemodynamic Changes Associated to Tracheal Extubation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Fernandez</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Fernandez</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Coughing during tracheal extubation can be associated to adverse effects like tachycardia,
      arterial hypertension (AHT), increase of intracranial pressure (ICP) and intraocular pressure
      (IOP), and the dehiscence of surgical wounds. In ophthalmic, head and neck, and abdominal
      surgery, and in several other neurosurgical interventions it is vital to prevent these
      effects. The incidence of laryngeal irritation due to orotracheal intubation hinders patient
      comfort in the immediate postoperative (POP) period and no pharmacological intervention has
      been yet proven to prevent it.

      At the end of the surgical procedure, the depth of the anesthetic plane decreases with the
      concomitant suspension of the anesthetic agents. However, the patient still requires
      ventilatory support through the endotracheal tube (EDT). The physical stimulation of the
      trachea created by this foreign body leads to the activation of the sympathetic nervous
      system, expressed in AHT, tachycardia, and ICP. To tolerate the EDT and prevent these
      effects, different maneuvers have been tested such as extubating the patient in a deep
      anesthetic plane or administering intravenous (IV) narcotics with the entailed complications:
      airway (AW) obstruction and hypercapnia, and the aspiration of an unprotected AW. Progress
      has been made with the introduction of ultrashort acting opioids, with significant
      statistical results. Moreover, beta-blockers, calcium channel blockers, angiotensin
      converting enzyme inhibitors and dexmedetomidine have been used to decrease the hemodynamic
      impact associated to tracheal extubation. The use of both IV and intratracheal lidocaine in
      doses ranging from 1 mg/kg to 3 mg/kg, has been studied with controversial results.

      In view of the above, and as lidocaine is the most commonly used low-cost drug in all
      operating rooms with a good safety profile when used at low doses, the purpose of this study
      is twofold: to assess its effects at reducing coughing and to evaluate its hemodynamic impact
      when administering IV 1 mg/kg prior to extubation. Then, the efficiency of reducing the
      incidence of sore throats after the immediate POP shall be investigated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2019</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">September 19, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This study was designed as a double-blind randomized controlled trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the efficiency of IV lidocaine in reducing the incidence of coughing</measure>
    <time_frame>From the moment the endotracheal tube is retired to 5 minutes after</time_frame>
    <description>Apply the Minogue scale to assess the coughing associated to tracheal extubation.
Modified Minogue scale by Likert: (ordinal, 0 to 5)
Grade 1: absence of coughing and muscle stiffness Grade 2: transient coughing while removing EDT Grade 3: moderate cough (3 or less coughing episodes each lasting one or two seconds) Grade 4: muscular stiffness or severe cough (4 ore more episodes lasting more tham two seconds) Grade 5: laryngospasm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the efficiency of IV lidocaine in reducing the arterial hypertension associated with tracheal extubation</measure>
    <time_frame>From the end of anesthesia to 5 minutes after tracheal extubation (At time 0, time 2 and time 3)</time_frame>
    <description>Gather mean arterial pressure (MAP) record at the time of the extubation.
Difference in MAP between anesthesia ceasing (time 0) and extubation (time 2) (continuous, mmHg) Difference in MAP between time 0 and 5 minutes after extubation (time 3) (continuous, mmHg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Determine the efficiency of IV lidocaine in reducing the increase in heart rate (HR) associated with tracheal extubation</measure>
    <time_frame>From the end of anesthesia to 5 minutes after tracheal extubation (At time 0, time 2 and time 3)</time_frame>
    <description>Gather HR record at the time of the extubation.
Difference in HR between time 0 and time 2 (discreet, bpm) Difference in HR between time 0 and time 3 (discreet, bpm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Record the time elapsed from the end of anesthesia and the administration of lidocaine to extubation.</measure>
    <time_frame>Intraoperative. From the end of anesthesia (time 0) to tracheal extubation (time 2)</time_frame>
    <description>As a safety event. Record time between t0 and t2 (continuous, minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess immediate POP sore throat</measure>
    <time_frame>30 minutes after extubation</time_frame>
    <description>using the Likert ten-point severity pain scale. The scale ranges from 0 to 10. 0 equals no pain, and 10 indicates the worst pain.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Monitor the adverse reactions (AR) that may occur after the administration of IV lidocaine and report them</measure>
    <time_frame>24 hours after extubation</time_frame>
    <description>Severe and unexpected AR shall be reported according to Argentina's National Administration of Drugs, Food and Medical Technology (ANMAT) with the means appropriate and intended for that purpose. Likewise, this scenario will be immediately reported to the Fernández hospital Ethics and Research Committee.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Lidocaine</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group that receives a 1 mg/kg single bolus of 2% IV lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>group that receives 0.9% saline solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>prior to extubation</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>GOBBI</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline Solution</intervention_name>
    <description>Prior to extubation</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>GOBBI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  American Society of Anesthesiologists Risk I &amp; II.

          -  Age 18-65 years.

          -  Scheduled for: cholecystectomy, hernioplasty or laparoscopic gynecological surgery,
             under balanced general anesthesia (GA) and orotracheal intubation (OTI).

        Exclusion criteria:

          -  Local anesthetic (LA) allergy.

          -  Presence of predictors of potentially difficult intubation (DI) according to criteria
             defined by the American Society of Anesthesiologists.

          -  Upper airway inflammatory symptoms during the previous week.

          -  Chronic kidney disease with clearance lower than 60 ml/m using the Modification of
             Diet in Renal Disease (MDRD) equation.

          -  Child-Pugh B-C liver disease.

          -  Treated with ACEinhibitors and/or BB.

          -  Second and third grade atrioventricular block.

          -  Symptomatic bradycardia.

          -  Tachyarrhythmias.

          -  Left bundle branch block (LBBB).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Santiago Ficcadenti, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Fernandez</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sofia De Estrada, Doctor</last_name>
    <phone>+5491151096340</phone>
    <email>sofiaestrada89@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fernando Sanchez Casco, Doctor</last_name>
    <phone>+5491158842153</phone>
    <email>fersanchezcasco92@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Fernandez</name>
      <address>
        <city>Capital federal</city>
        <state>Buenos Aires</state>
        <zip>1425</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sofia De Estrada, Doctor</last_name>
      <phone>+5491151096340</phone>
      <email>Sofiaestrada89@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Santiago Ficcadenti, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sofia De Estrada, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Sanchez Casco, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nicolas Tentoni, Doctor</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <results_reference>
    <citation>Minogue SC, Ralph J, Lampa MJ. Laryngotracheal topicalization with lidocaine before intubation decreases the incidence of coughing on emergence from general anesthesia. Anesth Analg. 2004 Oct;99(4):1253-7, table of contents.</citation>
    <PMID>15385385</PMID>
  </results_reference>
  <results_reference>
    <citation>Hohlrieder M, Tiefenthaler W, Klaus H, Gabl M, Kavakebi P, Keller C, Benzer A. Effect of total intravenous anaesthesia and balanced anaesthesia on the frequency of coughing during emergence from the anaesthesia. Br J Anaesth. 2007 Oct;99(4):587-91. Epub 2007 Jul 27.</citation>
    <PMID>17660457</PMID>
  </results_reference>
  <results_reference>
    <citation>Bruder N, Pellissier D, Grillot P, Gouin F. Cerebral hyperemia during recovery from general anesthesia in neurosurgical patients. Anesth Analg. 2002 Mar;94(3):650-4; table of contents.</citation>
    <PMID>11867391</PMID>
  </results_reference>
  <results_reference>
    <citation>Coles JP, Leary TS, Monteiro JN, Brazier P, Summors A, Doyle P, Matta BF, Gupta AK. Propofol anesthesia for craniotomy: a double-blind comparison of remifentanil, alfentanil, and fentanyl. J Neurosurg Anesthesiol. 2000 Jan;12(1):15-20.</citation>
    <PMID>10636615</PMID>
  </results_reference>
  <results_reference>
    <citation>Talke P, Caldwell JE, Brown R, Dodson B, Howley J, Richardson CA. A comparison of three anesthetic techniques in patients undergoing craniotomy for supratentorial intracranial surgery. Anesth Analg. 2002 Aug;95(2):430-5, table of contents.</citation>
    <PMID>12145066</PMID>
  </results_reference>
  <results_reference>
    <citation>Christensen AM, Willemoes-Larsen H, Lundby L, Jakobsen KB. Postoperative throat complaints after tracheal intubation. Br J Anaesth. 1994 Dec;73(6):786-7.</citation>
    <PMID>7880666</PMID>
  </results_reference>
  <results_reference>
    <citation>Harding CJ, McVey FK. Interview method affects incidence of postoperative sore throat. Anaesthesia. 1987 Oct;42(10):1104-7.</citation>
    <PMID>3688395</PMID>
  </results_reference>
  <results_reference>
    <citation>Herlevsen P, Bredahl C, Hindsholm K, Kruhøffer PK. Prophylactic laryngo-tracheal aerosolized lidocaine against postoperative sore throat. Acta Anaesthesiol Scand. 1992 Aug;36(6):505-7.</citation>
    <PMID>1514331</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee B, Lee JR, Na S. Targeting smooth emergence: the effect site concentration of remifentanil for preventing cough during emergence during propofol-remifentanil anaesthesia for thyroid surgery. Br J Anaesth. 2009 Jun;102(6):775-8. doi: 10.1093/bja/aep090. Epub 2009 May 2.</citation>
    <PMID>19411668</PMID>
  </results_reference>
  <results_reference>
    <citation>Mayhan WG. Disruption of blood-brain barrier during acute hypertension in adult and aged rats. Am J Physiol. 1990 Jun;258(6 Pt 2):H1735-8.</citation>
    <PMID>2113773</PMID>
  </results_reference>
  <results_reference>
    <citation>Gauthier A, Girard F, Boudreault D, Ruel M, Todorov A. Sevoflurane provides faster recovery and postoperative neurological assessment than isoflurane in long-duration neurosurgical cases. Anesth Analg. 2002 Nov;95(5):1384-8, table of contents.</citation>
    <PMID>12401630</PMID>
  </results_reference>
  <results_reference>
    <citation>Lowrie A, Johnston PL, Fell D, Robinson SL. Cardiovascular and plasma catecholamine responses at tracheal extubation. Br J Anaesth. 1992 Mar;68(3):261-3.</citation>
    <PMID>1547048</PMID>
  </results_reference>
  <results_reference>
    <citation>Grillo P, Bruder N, Auquier P, Pellissier D, Gouin F. Esmolol blunts the cerebral blood flow velocity increase during emergence from anesthesia in neurosurgical patients. Anesth Analg. 2003 Apr;96(4):1145-9, table of contents.</citation>
    <PMID>12651674</PMID>
  </results_reference>
  <results_reference>
    <citation>Muzzi DA, Black S, Losasso TJ, Cucchiara RF. Labetalol and esmolol in the control of hypertension after intracranial surgery. Anesth Analg. 1990 Jan;70(1):68-71.</citation>
    <PMID>1967515</PMID>
  </results_reference>
  <results_reference>
    <citation>Fujii Y, Saitoh Y, Takahashi S, Toyooka H. Combined diltiazem and lidocaine reduces cardiovascular responses to tracheal extubation and anesthesia emergence in hypertensive patients. Can J Anaesth. 1999 Oct;46(10):952-6. Retraction in: Can J Anaesth. 2013 Jun;60(6):613.</citation>
    <PMID>10522582</PMID>
  </results_reference>
  <results_reference>
    <citation>Tsutsui T. Combined administration of diltiazem and nicardipine attenuates hypertensive responses to emergence and extubation. J Neurosurg Anesthesiol. 2002 Apr;14(2):89-95.</citation>
    <PMID>11907387</PMID>
  </results_reference>
  <results_reference>
    <citation>Kross RA, Ferri E, Leung D, Pratila M, Broad C, Veronesi M, Melendez JA. A comparative study between a calcium channel blocker (Nicardipine) and a combined alpha-beta-blocker (Labetalol) for the control of emergence hypertension during craniotomy for tumor surgery. Anesth Analg. 2000 Oct;91(4):904-9.</citation>
    <PMID>11004045</PMID>
  </results_reference>
  <results_reference>
    <citation>Tanskanen PE, Kyttä JV, Randell TT, Aantaa RE. Dexmedetomidine as an anaesthetic adjuvant in patients undergoing intracranial tumour surgery: a double-blind, randomized and placebo-controlled study. Br J Anaesth. 2006 Nov;97(5):658-65. Epub 2006 Aug 16. Erratum in: Br J Anaesth. 2006 Dec;97(6):908.</citation>
    <PMID>16914460</PMID>
  </results_reference>
  <results_reference>
    <citation>Nho JS, Lee SY, Kang JM, Kim MC, Choi YK, Shin OY, Kim DS, Kwon MI. Effects of maintaining a remifentanil infusion on the recovery profiles during emergence from anaesthesia and tracheal extubation. Br J Anaesth. 2009 Dec;103(6):817-21. doi: 10.1093/bja/aep307. Epub 2009 Oct 28.</citation>
    <PMID>19864308</PMID>
  </results_reference>
  <results_reference>
    <citation>Shajar MA, Thompson JP, Hall AP, Leslie NA, Fox AJ. Effect of a remifentanil bolus dose on the cardiovascular response to emergence from anaesthesia and tracheal extubation. Br J Anaesth. 1999 Oct;83(4):654-6.</citation>
    <PMID>10673886</PMID>
  </results_reference>
  <results_reference>
    <citation>Ghodraty MR, Hasani V, Bagheri-Aghdam A, Zamani MM, Pournajafian A, Rokhtabnak F, Kholdebarin A, Nader ND. Remifentanil infusion during emergence moderates hemodynamic and cough responses to the tracheal tube: A randomized controlled trial. J Clin Anesth. 2016 Sep;33:514-20. doi: 10.1016/j.jclinane.2015.09.001. Epub 2015 Oct 23.</citation>
    <PMID>26603110</PMID>
  </results_reference>
  <results_reference>
    <citation>Altintaş F, Bozkurt P, Kaya G, Akkan G. Lidocaine 10% in the endotracheal tube cuff: blood concentrations, haemodynamic and clinical effects. Eur J Anaesthesiol. 2000 Jul;17(7):436-42.</citation>
    <PMID>10964145</PMID>
  </results_reference>
  <results_reference>
    <citation>Prengel AW, Lindner KH, Hähnel JH, Georgieff M. Pharmacokinetics and technique of endotracheal and deep endobronchial lidocaine administration. Anesth Analg. 1993 Nov;77(5):985-9.</citation>
    <PMID>8214738</PMID>
  </results_reference>
  <results_reference>
    <citation>Baraka A. Intravenous lidocaine controls extubation laryngospasm in children. Anesth Analg. 1978 Jul-Aug;57(4):506-7.</citation>
    <PMID>360878</PMID>
  </results_reference>
  <results_reference>
    <citation>Bidwai AV, Bidwai VA, Rogers CR, Stanley TH. Blood-pressure and pulse-rate responses to endotracheal extubation with and without prior injection of lidocaine. Anesthesiology. 1979 Aug;51(2):171-3.</citation>
    <PMID>453622</PMID>
  </results_reference>
  <results_reference>
    <citation>Copeland SE, Ladd LA, Gu XQ, Mather LE. The effects of general anesthesia on whole body and regional pharmacokinetics of local anesthetics at toxic doses. Anesth Analg. 2008 May;106(5):1440-9, table of contents. doi: 10.1213/ane.0b013e31816ba541.</citation>
    <PMID>18420858</PMID>
  </results_reference>
  <results_reference>
    <citation>Copeland SE, Ladd LA, Gu XQ, Mather LE. The effects of general anesthesia on the central nervous and cardiovascular system toxicity of local anesthetics. Anesth Analg. 2008 May;106(5):1429-39, table of contents. doi: 10.1213/ane.0b013e31816d12af.</citation>
    <PMID>18420857</PMID>
  </results_reference>
  <results_reference>
    <citation>Shankar Ramaswamy, John A. Wilson, Lesley Colvin. Non-opioid-based adjuvant analgesia in perioperative care. Continuing Education in Anaesthesia, Critical Care &amp; Pain. 2013; 13:152-7.</citation>
  </results_reference>
  <results_reference>
    <citation>N Eipe, S Gupta, J Penning. Intravenous lidocaine for acute pain: an evidence-based clinical update. Br J Anaesth Education. 2016; 16:292-8.</citation>
  </results_reference>
  <results_reference>
    <citation>Mazzone SB, Undem BJ. Cough sensors. V. Pharmacological modulation of cough sensors. Handb Exp Pharmacol. 2009;(187):99-127. doi: 10.1007/978-3-540-79842-2_6. Review.</citation>
    <PMID>18825338</PMID>
  </results_reference>
  <results_reference>
    <citation>STEINHAUS JE, GASKIN L. A study of intravenous lidocaine as a suppressant of cough reflex. Anesthesiology. 1963 May-Jun;24:285-90.</citation>
    <PMID>13983769</PMID>
  </results_reference>
  <results_reference>
    <citation>Martínez-Zúñiga JP, Lorenzo-Balderas, Silva-Escobedo JG. Lidocaine in low doses combining intravenous and endotracheal therapies: reduces incidence of coughing and hemodynamic changes during extubation. Rev Sanid Milit Mex. 2011; 65:95-8.</citation>
  </results_reference>
  <results_reference>
    <citation>Zamora Lozano J, Cruz Villaseñor JA, Rodríguez Reyes J, Sánchez Rodríguez JP, Briones Corona G, Gallardo Alonso LA. [Comparison of topical, intravenous, and intracuff lidocaine for reducing coughing after extubation during emergence from general anesthesia]. Rev Esp Anestesiol Reanim. 2007 Dec;54(10):596-601. Spanish.</citation>
    <PMID>18200994</PMID>
  </results_reference>
  <results_reference>
    <citation>Saghaei M, Reisinejad A, Soltani H. Prophylactic versus therapeutic administration of intravenous lidocaine for suppression of post-extubation cough following cataract surgery: a randomized double blind placebo controlled clinical trial. Acta Anaesthesiol Taiwan. 2005 Dec;43(4):205-9.</citation>
    <PMID>16450594</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee JH, Koo BN, Jeong JJ, Kim HS, Lee JR. Differential effects of lidocaine and remifentanil on response to the tracheal tube during emergence from general anaesthesia. Br J Anaesth. 2011 Mar;106(3):410-5. doi: 10.1093/bja/aeq396. Epub 2011 Jan 2.</citation>
    <PMID>21205628</PMID>
  </results_reference>
  <results_reference>
    <citation>Williams KA, Barker GL, Harwood RJ, Woodall NM. Combined nebulization and spray-as-you-go topical local anaesthesia of the airway. Br J Anaesth. 2005 Oct;95(4):549-53. Epub 2005 Aug 26.</citation>
    <PMID>16126785</PMID>
  </results_reference>
  <results_reference>
    <citation>Mainland PA, Kong AS, Chung DC, Chan CH, Lai CK. Absorption of lidocaine during aspiration anesthesia of the airway. J Clin Anesth. 2001 Sep;13(6):440-6.</citation>
    <PMID>11578889</PMID>
  </results_reference>
  <results_reference>
    <citation>Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med. 2004 Nov-Dec;29(6):564-75; discussion 524. Review.</citation>
    <PMID>15635516</PMID>
  </results_reference>
  <results_reference>
    <citation>Donald MJ, Derbyshire S. Lignocaine toxicity; a complication of local anaesthesia administered in the community. Emerg Med J. 2004 Mar;21(2):249-50.</citation>
    <PMID>14988367</PMID>
  </results_reference>
  <results_reference>
    <citation>Scuderi PE. Postoperative sore throat: more answers than questions. Anesth Analg. 2010 Oct;111(4):831-2. doi: 10.1213/ANE.0b013e3181ee85c7.</citation>
    <PMID>20870978</PMID>
  </results_reference>
  <results_reference>
    <citation>Minto CF, Schnider TW, Egan TD, Youngs E, Lemmens HJ, Gambus PL, Billard V, Hoke JF, Moore KH, Hermann DJ, Muir KT, Mandema JW, Shafer SL. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology. 1997 Jan;86(1):10-23.</citation>
    <PMID>9009935</PMID>
  </results_reference>
  <results_reference>
    <citation>Minto CF, Schnider TW, Shafer SL. Pharmacokinetics and pharmacodynamics of remifentanil. II. Model application. Anesthesiology. 1997 Jan;86(1):24-33.</citation>
    <PMID>9009936</PMID>
  </results_reference>
  <results_reference>
    <citation>Kapila A, Glass PS, Jacobs JR, Muir KT, Hermann DJ, Shiraishi M, Howell S, Smith RL. Measured context-sensitive half-times of remifentanil and alfentanil. Anesthesiology. 1995 Nov;83(5):968-75.</citation>
    <PMID>7486182</PMID>
  </results_reference>
  <results_reference>
    <citation>Bürkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting, mu-opioid. Anesth Analg. 1996 Sep;83(3):646-51. Review.</citation>
    <PMID>8780298</PMID>
  </results_reference>
  <results_reference>
    <citation>Egan TD, Lemmens HJ, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology. 1993 Nov;79(5):881-92.</citation>
    <PMID>7902032</PMID>
  </results_reference>
  <results_reference>
    <citation>Kim H, Min KT, Lee JR, Ha SH, Lee WK, Seo JH, Choi SH. Comparison of Dexmedetomidine and Remifentanil on Airway Reflex and Hemodynamic Changes during Recovery after Craniotomy. Yonsei Med J. 2016 Jul;57(4):980-6. doi: 10.3349/ymj.2016.57.4.980.</citation>
    <PMID>27189295</PMID>
  </results_reference>
  <results_reference>
    <citation>Ikeda Y, Oda Y, Nakamura T, Takahashi R, Miyake W, Hase I, Asada A. Pharmacokinetics of lidocaine, bupivacaine, and levobupivacaine in plasma and brain in awake rats. Anesthesiology. 2010 Jun;112(6):1396-403. doi: 10.1097/ALN.0b013e3181d9cc54.</citation>
    <PMID>20460991</PMID>
  </results_reference>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>November 2, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2018</study_first_posted>
  <last_update_submitted>February 11, 2020</last_update_submitted>
  <last_update_submitted_qc>February 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Fernandez</investigator_affiliation>
    <investigator_full_name>Santiago Ficcadenti</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Cough</keyword>
  <keyword>Sore throat</keyword>
  <keyword>Hemodynamic changes</keyword>
  <keyword>Extubation</keyword>
  <keyword>Lidocaine</keyword>
  <keyword>Double blind</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

